Cite
HARVARD Citation
Hertzberg, M. et al. (n.d.). A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. American journal of hematology. 89 (5), pp. 536-541. [Online].